Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.77 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.62 |
| ▸ | TUBB | P07437 | 2/20 | 0.62 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.62 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.62 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.62 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.62 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.62 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.62 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.62 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.62 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.62 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7557760 | 0.86 | MAPT (0.74) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7557764 | 0.86 | MAPT (0.74) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7532157 | 0.84 | MAPT (0.83) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7566603 | 0.84 | MAPT (0.83) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7673063 | 0.78 | MAPT (0.70) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7527624 | 0.78 | MAPT (0.70) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7562862 | 0.78 | MAPT (0.64) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7562857 | 0.78 | MAPT (0.64) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7560117 | 0.78 | MAPT (0.64) | MAPTLMNASMN1; SMN2THRBMEN1 | |
| SCHEMBL7560111 | 0.78 | MAPT (0.64) | MAPTLMNASMN1; SMN2THRBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030105140-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2003-06-05 | — | — | US | claimed |
| WO-2002102301-A2 | SUBSTITUTED INDOLE-2-CARBOXYLIC ACID BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2002-12-27 | — | — | WO | claimed |
| US-20020128292-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2002-09-12 | — | — | US | claimed |
| US-6747052-B2 | ANTICANCER AGENTS | CYTOVIA, INC. | 2004-06-08 | — | — | US | disclosed |
| US-20030105140-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2003-06-05 | — | — | US | disclosed |
| WO-2002102301-A2 | SUBSTITUTED INDOLE-2-CARBOXYLIC ACID BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2002-12-27 | — | — | WO | disclosed |
| US-20020128292-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2002-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128292-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | BAD, API5, CASP2 | MAPT 4140/4885LMNA 1924/4885SMN1; SMN2 4410/4885 |
| US-20030105140-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | BAD, API5, CASP2 | MAPT 4140/4885LMNA 1924/4885SMN1; SMN2 4410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.